Vitamin K1 (Phylloquinone) 是一种脂溶性的、来源于植物的天然维生素。
Cas No.:84-80-0
Sample solution is provided at 25 µL, 10mM.
Vitamin K1 (Phylloquinone) is a fat-soluble, plant-derived natural vitamin. Vitamin K1 serves as an essential cofactor for γ-glutamyl carboxylase (GGCX) to promote the γ-carboxylation of coagulation factors II, VII, IX, and X, enabling them to bind calcium ions and exert normal coagulation function. Vitamin K1 reduces oxidative stress and cellular damage by inhibiting 12-lipoxygenase (12-LOX) activation. Vitamin K1 can be used in research related to bleeding disorders, cancer, and other diseases[1-4].
In vitro, Vitamin K1 (6–24μM) was used to treat PLC/PRF/5, HLF, and Hep3B human hepatocellular carcinoma cells for 72 hours. Vitamin K1 significantly inhibited cell migration while causing a reduction in polymerized F-actin and its perinuclear redistribution[5]. Vitamin K1 (10–200μM) was used to treat Caco-2, HT-29, and SW480 human colon cancer cell lines for 24–72 hours. Vitamin K1 significantly inhibited cell proliferation, induced apoptosis, and concurrently reduced polyamine biosynthesis[6].
In vivo, Vitamin K1 (1–3mg/kg) was administered by gavage once daily for one week as pretreatment, followed by an intraperitoneal injection of acetaminophen (APAP; 200mg/kg) on the final day in Albino mice. Vitamin K1 dose-dependently attenuated APAP-induced liver injury[7]. Vitamin K1 (1mg/kg; single dose) was administered by gavage to C57BL/6 mice that received an intraperitoneal injection of LPS (15mg/kg). Vitamin K1 ameliorated LPS-triggered skeletal muscle injury[8].
References:
[1] Halder M, Petsophonsakul P, Akbulut AC, et al. Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease. Int J Mol Sci. 2019 Feb 19;20(4):896.
[3] Basset GJ, Latimer S, Fatihi A, et al. Phylloquinone (Vitamin K1): Occurrence, Biosynthesis and Functions. Mini Rev Med Chem. 2017;17(12):1028-1038.
[4] Britt RB, Brown JN. Characterizing the Severe Reactions of Parenteral Vitamin K1. Clin Appl Thromb Hemost. 2018 Jan;24(1):5-12.
[5] D'Alessandro R, Refolo MG, Lippolis C, et al. Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1. Cell Oncol (Dordr). 2018 Jun;41(3):283-296.
[6] Orlando A, Linsalata M, Tutino V, et al. Vitamin K1 exerts antiproliferative effects and induces apoptosis in three differently graded human colon cancer cell lines. Biomed Res Int. 2015;2015:296721.
[7] Abass SA, Mohamed AA, El-Slam AHA, et al. Vitamin K1 attenuates acetaminophen-induced ferroptotic hepatic damage in mice via targeting keap1/Nrf2/HO-1 pathway. Naunyn Schmiedebergs Arch Pharmacol. 2026 Feb;399(3):3699-3713.
[8] Xiao Y, Feng J, Jia J, et al. Vitamin K1 ameliorates lipopolysaccharide-triggered skeletal muscle damage revealed by faecal bacteria transplantation. J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):81-97.
Vitamin K1 (Phylloquinone) 是一种脂溶性的、来源于植物的天然维生素。Vitamin K1可作为γ-谷氨酰羧化酶(GGCX)的必需辅因子来促进凝血因子II、VII、IX、X的γ-羧基化,使其能够结合钙离子并发挥正常的凝血功能。Vitamin K1通过抑制12-脂氧合酶(12-LOX)激活以减少氧化应激和细胞损伤。Vitamin K1可用于出血性疾病、癌症等疾病的相关研究[1-4]。
在体外,Vitamin K1(6–24μM)处理PLC/PRF/5、HLF和Hep3B人肝细胞癌细胞72小时。Vitamin K1显著抑制细胞迁移,同时引起聚合F-actin减少和核周重新分布[5]。Vitamin K1(10–200μM)处理Caco-2、HT-29和SW480人结肠癌细胞系24–72小时。Vitamin K1显著抑制细胞增殖,诱导细胞凋亡,同时降低多胺生物合成[6]。
在体内,Vitamin K1(1–3mg/kg)每天一次灌胃预处理一周,随后在最后一天腹腔注射Acetaminophen(200mg/kg)处理Albino小鼠。Vitamin K1剂量依赖性地减轻了APAP诱导的肝损伤[7]。Vitamin K1(1mg/kg/kg;单次)灌胃于腹腔注射LPS(15mg/kg)的C57BL/6小鼠。Vitamin K1改善了LPS触发的骨骼肌损伤[8]。
| Cell experiment [1]: | |
Cell lines | Caco-2, HT-29, and SW480 human colon cancer cell lines |
Preparation Method | Cells were cultured in RPMI-1640, McCoy's 5A, and Leibovitz L-15 medium, respectively, supplemented with 10% fetal bovine serum (FBS), 2mM glutamine, 100U/mL penicillin, and 100μg/mL streptomycin at 37°C in a humidified atmosphere containing 5% CO₂. Cells were treated with increasing concentrations of Vitamin K1 (from 10μM to 200μM) for 24h, 48h, and 72h. |
Reaction Conditions | 10–200μM; 24–72h |
Applications | Vitamin K1 treatment caused a significant antiproliferative effect and induced apoptosis in all the cell lines, with the involvement of the MAPK pathway. A concomitant and significant decrease in the polyamine biosynthesis occurred. |
| Animal experiment [2]: | |
Animal models | Male albino mice (16-28g) |
Preparation Method | Mice were pretreated with Vitamin K1 (1, 2, or 3mg/kg) by gavage once daily for one week, followed by a single intraperitoneal injection of acetaminophen (APAP; 200mg/kg) on the last day. Blood and liver samples were collected after overnight fasting for biochemical and histopathological analysis. |
Dosage form | 1, 2, or 3mg/kg; gavage; once daily for one week |
Applications | Vitamin K1 pretreatment dose-dependently attenuated APAP-induced liver injury, as evidenced by reduced serum ALT and AST levels, increased albumin, decreased oxidative stress markers (MDA, NO), increased GSH, elevated GPX4, reduced hepatic iron content and ACSL4 expression, and modulation of the Keap1/Nrf2/HO-1 pathway. |
References: | |
| Cas No. | 84-80-0 | SDF | |
| 别名 | 叶绿醌; Phylloquinone; Phytomenadione | ||
| Canonical SMILES | O=C1C(C)=C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(C2=C1C=CC=C2)=O | ||
| 分子式 | C31H46O2 | 分子量 | 450.7 |
| 溶解度 | Ethanol : ≥ 50 mg/mL (110.94 mM);DMSO : 5.6 mg/mL (12.43 mM) | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.2188 mL | 11.0939 mL | 22.1877 mL |
| 5 mM | 443.8 μL | 2.2188 mL | 4.4375 mL |
| 10 mM | 221.9 μL | 1.1094 mL | 2.2188 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A Liquid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















